-
Something wrong with this record ?
Outcome of patients with acute symptomatic pulmonary embolism and psychiatric disorders
D. Velasco, D. Jiménez, B. Bikdeli, A. Muriel, PJ. Marchena, I. Tzoran, R. Malý, R. López-Reyes, A. Riera-Mestre, M. Monreal, RIETE investigators
Language English Country United States
Document type Journal Article, Research Support, Non-U.S. Gov't
- MeSH
- Acute Disease MeSH
- Adult MeSH
- Mental Disorders * complications MeSH
- Humans MeSH
- Pulmonary Embolism * complications MeSH
- Prognosis MeSH
- Registries MeSH
- Risk Factors MeSH
- Venous Thromboembolism * MeSH
- Check Tag
- Adult MeSH
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
OBJECTIVE: To address the association between psychiatric disorders and short-term outcomes after acute symptomatic pulmonary embolism (PE). METHODS: We identified adults with PE enrolled in the RIETE registry between December 1, 2013, and January 31, 2019. Using multinomial regression, we assessed the association between a history of psychiatric disorders and the outcomes of all-cause mortality, PE-related mortality, and venous thromboembolism recurrence and bleeding rates through 30 days after initiation of treatment. We also examined the impact of depression on all-cause and PE-specific mortality. RESULTS: Among 13,120 patients diagnosed with acute PE, 16.1% (2115) had psychiatric disorders and 4.2% died within the first 30-days of follow-up. Patients with psychiatric disorders had increased odds for all-cause (adjusted odds ratio [OR] 1.50; 95% CI, 1.21 to 1.86; P < 0.001) and PE-related mortality (adjusted OR 1.64; 95% CI, 1.09 to 2.48; P = 0.02) compared to those without psychiatric disorders. Multinomial logistic regression showed a non-significant trend toward lower risk of recurrences for patients with psychiatric disorders (adjusted OR 0.49; 95% CI, 0.21 to 1.15; P = 0.10). Psychiatric disorders were not significantly associated with increased odds for major bleeds during follow-up (adjusted OR 1.09; 95% CI, 0.85 to 1.40; P = 0.49). Results were consistent in a sensitivity analysis that only considered patients with a diagnosis of depression. CONCLUSIONS: In patients with acute PE, history of psychiatric disorders might predict all-cause and PE-related death in the ensuing month after diagnosis.
Cardiovascular Research Foundation New York USA
Center for Outcomes Research and Evaluation Yale University School of Medicine New Haven USA
CIBER de Enfermedades Respiratorias Instituto de Salud Carlos 3 Madrid Spain
Department of Hematology and Bone Marrow Transplantation Rambam Health Care Campus Haifa Israel
Department of Internal Medicine Hospital Universitari Germans Trias i Pujol Badalona Barcelona Spain
Department of Pneumonology Hospital Universitari i Politècnic La Fe Valencia Spain
Medicine Department Universidad de Alcala Madrid Spain
Respiratory Department Hospital Ramón y Cajal Madrid Spain
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21020227
- 003
- CZ-PrNML
- 005
- 20210830101839.0
- 007
- ta
- 008
- 210728s2020 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.thromres.2020.05.052 $2 doi
- 035 __
- $a (PubMed)32531549
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Velasco, Diurbis $u Respiratory Department, Hospital Ramón y Cajal (IRYCIS), Madrid, Spain
- 245 10
- $a Outcome of patients with acute symptomatic pulmonary embolism and psychiatric disorders / $c D. Velasco, D. Jiménez, B. Bikdeli, A. Muriel, PJ. Marchena, I. Tzoran, R. Malý, R. López-Reyes, A. Riera-Mestre, M. Monreal, RIETE investigators
- 520 9_
- $a OBJECTIVE: To address the association between psychiatric disorders and short-term outcomes after acute symptomatic pulmonary embolism (PE). METHODS: We identified adults with PE enrolled in the RIETE registry between December 1, 2013, and January 31, 2019. Using multinomial regression, we assessed the association between a history of psychiatric disorders and the outcomes of all-cause mortality, PE-related mortality, and venous thromboembolism recurrence and bleeding rates through 30 days after initiation of treatment. We also examined the impact of depression on all-cause and PE-specific mortality. RESULTS: Among 13,120 patients diagnosed with acute PE, 16.1% (2115) had psychiatric disorders and 4.2% died within the first 30-days of follow-up. Patients with psychiatric disorders had increased odds for all-cause (adjusted odds ratio [OR] 1.50; 95% CI, 1.21 to 1.86; P < 0.001) and PE-related mortality (adjusted OR 1.64; 95% CI, 1.09 to 2.48; P = 0.02) compared to those without psychiatric disorders. Multinomial logistic regression showed a non-significant trend toward lower risk of recurrences for patients with psychiatric disorders (adjusted OR 0.49; 95% CI, 0.21 to 1.15; P = 0.10). Psychiatric disorders were not significantly associated with increased odds for major bleeds during follow-up (adjusted OR 1.09; 95% CI, 0.85 to 1.40; P = 0.49). Results were consistent in a sensitivity analysis that only considered patients with a diagnosis of depression. CONCLUSIONS: In patients with acute PE, history of psychiatric disorders might predict all-cause and PE-related death in the ensuing month after diagnosis.
- 650 _2
- $a akutní nemoc $7 D000208
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a duševní poruchy $x komplikace $7 D001523
- 650 _2
- $a prognóza $7 D011379
- 650 12
- $a plicní embolie $x komplikace $7 D011655
- 650 _2
- $a registrace $7 D012042
- 650 _2
- $a rizikové faktory $7 D012307
- 650 12
- $a žilní tromboembolie $7 D054556
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Jiménez, David $u Respiratory Department, Hospital Ramón y Cajal (IRYCIS), Madrid, Spain; Medicine Department, Universidad de Alcala (IRYCIS), Madrid, Spain; CIBER de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Spain. Electronic address: djcastro@salud.madrid.org
- 700 1_
- $a Bikdeli, Behnood $u Division of Cardiology, Department of Medicine, Columbia University Medical Center, New York-Presbyterian Hospital, New York, USA; Center for Outcomes Research and Evaluation (CORE), Yale University School of Medicine, New Haven, USA; Cardiovascular Research Foundation, New York, USA
- 700 1_
- $a Muriel, Alfonso $u Biostatistics Department, Ramón y Cajal Hospital and Instituto Ramón y Cajal de Investigación Sanitaria IRYCIS, CIBERESP, Madrid, Spain
- 700 1_
- $a Marchena, Pablo Javier $u Department of Internal Medicine and Emergency, Parc Sanitari Sant Joan de Déu-Hospital General, Barcelona, Spain
- 700 1_
- $a Tzoran, Inna $u Department of Hematology and Bone Marrow Transplantation, Rambam Health Care Campus, Haifa, Israel
- 700 1_
- $a Malý, Radovan $u Department of Cardiovascular Medicine I, Charles University in Prague, Faculty of Medicine in Hradec Kralove, University Hospital Hradec Kralove, Czech Republic
- 700 1_
- $a López-Reyes, Raquel $u Department of Pneumonology, Hospital Universitari i Politècnic La Fe, Valencia, Spain
- 700 1_
- $a Riera-Mestre, Antoni $u Department of Internal Medicine, Hospital Universitari de Bellvitge - IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain; Universitat de Barcelona, Barcelona, Spain
- 700 1_
- $a Monreal, Manuel $u Department of Internal Medicine, Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain; Universidad Autónoma de Barcelona, Barcelona, Spain
- 710 2_
- $a RIETE investigators
- 773 0_
- $w MED00004518 $t Thrombosis research $x 1879-2472 $g Roč. 193, č. - (2020), s. 90-97
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/32531549 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20210728 $b ABA008
- 991 __
- $a 20210830101839 $b ABA008
- 999 __
- $a ok $b bmc $g 1690918 $s 1140673
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 193 $c - $d 90-97 $e 20200601 $i 1879-2472 $m Thrombosis research $n Thromb Res $x MED00004518
- LZP __
- $a Pubmed-20210728